Healthcare ❯Pharmaceuticals ❯Weight-loss Drugs
Mounjaro and Zepbound
The pharmaceutical giant saw strong demand for its diabetes and weight-loss drugs but missed revenue estimates due to lower realized prices and inventory issues.
